Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-05-14Collection & Extraction of Respiratory Specimens for the Validation of the Artus Influenza RG PCR Test
-
CLINICAL_TRIALS study record update · 2014-05-13A Phase II Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers.
-
CLINICAL_TRIALS study record update · 2014-05-12Phase 4 Study of Post-License Safety Evaluation of Influenza Split Vaccine
-
CLINICAL_TRIALS study record update · 2014-05-08A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older
-
CLINICAL_TRIALS study record update · 2014-04-30Clinical Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B in the Primary Health Setting
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-04-30A Phase I Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and the Viroflu® Seasonal Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2014-04-23Systems Biological Responses to Influenza Vaccination in an HIV-infected and HIV-uninfected Adult Population in Kampala, Uganda
-
CLINICAL_TRIALS study record update · 2014-04-16Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)
-
CLINICAL_TRIALS study record update · 2014-04-16Immunogenicity and Safety Study of GSK Biologicals' Monovalent Pandemic H5N1 Vaccine 1557484A in Adults Aged 18 - 64 Years
-
CLINICAL_TRIALS study record update · 2014-04-14A Randomized Open Label Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Amantadine and Ribavirin With Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects
-
CLINICAL_TRIALS study record update · 2014-04-08ClinicalTrials.gov study NCT01037205
-
CLINICAL_TRIALS study record update · 2014-04-03Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) When Administered in Children
-
CLINICAL_TRIALS study record update · 2014-03-31Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
-
CLINICAL_TRIALS study record update · 2014-03-27A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
-
CLINICAL_TRIALS study record update · 2014-03-26Safety and Immunogenicity Study of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine GSK1562902A in Children Aged 3 to 17 Years
-
CLINICAL_TRIALS study record update · 2014-03-04Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
-
CLINICAL_TRIALS study record update · 2014-02-28A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
-
CLINICAL_TRIALS study record update · 2014-02-24Drug Use Investigation for Arepanrix® (H1N1)
-
CLINICAL_TRIALS study record update · 2014-02-24Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine GSK 1557484A.
-
CLINICAL_TRIALS study record update · 2014-02-13A Phase 4, Randomized, Single-blind Trial to Evaluate Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine When Administered Simultaneously With Trivalent Inactivated Influenza Vaccine in Healthy Children Aged 3-7years and Healthy Adults 65 Aged 50-65years.
-
CLINICAL_TRIALS study record update · 2014-02-10Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in the United Kingdom
-
CLINICAL_TRIALS study record update · 2014-02-10Immunogenicity and Safety Trial of Quadrivalent Influenza Vaccine Administered by Intradermal Route in Adult Subjects Aged 18 Through 64 Years
-
CLINICAL_TRIALS study record update · 2014-02-07A Phase I/II, Observer-Blind, Randomized, Active-Controlled Trial to Evaluate the Safety and Immunogenicity of a Two-Dose Series of GSK Biologicals' Candidate Influenza Vaccine GSK 1557484A Antigens With or Without Adjuvant
-
CLINICAL_TRIALS study record update · 2014-02-07A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
-
CLINICAL_TRIALS study record update · 2014-02-07A Trial to Evaluate the Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults >=18 Yrs of Age